Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ResMed Inc. Common Stock
(NY:
RMD
)
246.88
-5.38 (-2.13%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ResMed Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
In today's session, there are S&P500 stocks with remarkable trading volume.
October 31, 2025
Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 stocks with an unusual volume in today's session.
Via
Chartmill
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
October 31, 2025
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
Via
Benzinga
Earnings Scheduled For October 30, 2025
October 30, 2025
Via
Benzinga
Gapping S&P500 stocks in Friday's session
October 31, 2025
Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via
Chartmill
RMD Q3 Deep Dive: ResMed Launches New Mask Platform and Invests in U.S. Operations
October 31, 2025
Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above...
Via
StockStory
Topics
Economy
These S&P500 stocks are moving in today's after hours session
October 30, 2025
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Via
Chartmill
Resmed Inc (NYSE:RMD) Reports Q1 FY2026 Results: Mixed Earnings Beat Fails to Prevent Stock Decline
October 30, 2025
Resmed's Q1 FY2026 earnings met expectations with $1.34B revenue and $2.55 EPS. Despite strong profit growth and margin expansion, the stock traded lower post-announcement.
Via
Chartmill
Topics
Earnings
ResMed (NYSE:RMD) Reports Q3 In Line With Expectations
October 30, 2025
Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above...
Via
StockStory
Insights into ResMed's Upcoming Earnings
October 29, 2025
Via
Benzinga
ResMed (RMD) Reports Q3: Everything You Need To Know Ahead Of Earnings
October 28, 2025
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
ResMed Inc (NYSE:RMD) Stands Out as a Quality Investment with Strong Financials
October 28, 2025
ResMed is a top-quality digital health stock with strong revenue growth, high profitability, and excellent cash flow conversion, making it a standout for long-term investors.
Via
Chartmill
1 Healthcare Stock to Research Further and 2 We Ignore
October 24, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...
Via
StockStory
Topics
Stocks
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
October 30, 2025
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...
Via
Benzinga
Topics
Economy
What 9 Analyst Ratings Have To Say About ResMed
October 21, 2025
Via
Benzinga
SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday
October 21, 2025
Via
Benzinga
ResMed Inc. (NYSE:RMD): A Dividend Stock with Strong Profitability and Financial Health
October 17, 2025
ResMed (RMD) is a reliable dividend stock with strong growth, high profitability, and a robust financial condition, ensuring sustainable payouts.
Via
Chartmill
2 Unpopular Stocks That Deserve a Second Chance and 1 That Underwhelm
October 17, 2025
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...
Via
StockStory
Heylo Appoints First CEO, Poised for Revolution in Remote Disability Support
October 14, 2025
Cincinnati-based startup Heylo has announced a significant stride in its mission to revolutionize care for individuals with intellectual and developmental disabilities (I/DD) with the appointment of...
Via
MarketMinute
Topics
Artificial Intelligence
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
October 13, 2025
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the...
Via
MarketMinute
2 Cash-Heavy Stocks to Research Further and 1 We Turn Down
October 13, 2025
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Via
StockStory
Topics
Electric Vehicles
World Trade
2 Cash-Heavy Stocks with Solid Fundamentals and 1 We Brush Off
October 13, 2025
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...
Via
StockStory
Topics
Electric Vehicles
World Trade
2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm
October 07, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via
StockStory
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
September 25, 2025
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...
Via
StockStory
Topics
World Trade
Which S&P500 stocks are gapping on Thursday?
September 25, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via
Chartmill
ResMed Inc. (NYSE:RMD) Offers a Reliable Dividend with Strong Financial Health
September 25, 2025
Learn how ResMed (RMD) exemplifies a strong dividend stock with a 10+ year growth streak, a low payout ratio, and robust profitability for reliable passive income.
Via
Chartmill
1 Cash-Producing Stock to Target This Week and 2 We Turn Down
September 23, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
September 18, 2025
Via
Benzinga
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
September 18, 2025
Via
Benzinga
This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
September 18, 2025
Via
Benzinga
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
September 17, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.